The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 05, 2019
Filed:
Dec. 01, 2017
Applicants:
Lead Pharma Holding B. V., Oss, NL;
Sanofi, Paris, FR;
Inventors:
Joseph Maria Gerardus Barbara Cals, Oss, NL;
David Machnik, Paris, FR;
Sander Bernardus Nabuurs, Oss, NL;
Jean-Francois Sabuco, Paris, FR;
Assignees:
LEAD PHARMA HOLDING B.V., Oss, NL;
SANOFI, Paris, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 317/32 (2006.01); A61P 17/00 (2006.01); A61P 19/02 (2006.01); A61P 1/00 (2006.01); A61P 25/00 (2006.01); C07C 315/04 (2006.01); A61K 31/10 (2006.01); A61K 31/167 (2006.01); C07C 317/44 (2006.01); C07C 317/46 (2006.01);
U.S. Cl.
CPC ...
C07C 317/32 (2013.01); A61K 31/10 (2013.01); A61K 31/167 (2013.01); A61P 1/00 (2018.01); A61P 17/00 (2018.01); A61P 19/02 (2018.01); A61P 25/00 (2018.01); C07C 315/04 (2013.01); C07C 317/44 (2013.01); C07C 317/46 (2013.01); C07C 2601/02 (2017.05);
Abstract
The present application relates to compounds according to (Formula IA) or (Formula IB): The compounds can be used as inhibitors of RORγ and are useful for the treatment of RORγ mediated diseases.